Improving medication management for seniors with major neurocognitive disorders
Official title: GPS Project - Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
Run by CHU de Quebec-Universite Laval · NCT04889794 · Data updated 2026-11-12
This study is testing a new way for doctors, nurses, and pharmacists to work together to help seniors with major neurocognitive disorders manage their medications better and stay healthy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | CHU de Quebec-Universite Laval Academic / other |
| Locations | 2 sites (Montreal, Quebec and 1 other locations) |
| Status | Recruiting |
| Started | September 27, 2021 |
| Main results expected | July 2025 |
| Study ends | December 2026 |
| Registry record updated | August 22, 2024 |
| Trial ID | NCT04889794 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are seniors aged 65 and older who are undergoing cognitive evaluation or have been diagnosed with major neurocognitive disorders and are taking prescription medications.
✕Probably not a fit
Patients in palliative care or those unable to respond to questionnaires in French without a caregiver may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to enhance pharmacotherapy for seniors with major neurocognitive disorders by implementing a new care model that promotes collaboration among healthcare professionals, including pharmacists, nurses, and doctors. The intervention involves knowledge exchange sessions and support for seniors to reduce polypharmacy and inappropriate medications while maintaining their cognitive health and autonomy. Approximately 400 seniors will be divided into intervention and control groups to evaluate the effectiveness of the new care approach over a 12-month period, with follow-up assessments conducted for about 6 months.
Why it matters
Potential benefit: If successful, this project could significantly improve the quality of life and cognitive health of seniors with major neurocognitive disorders.
How similar studies have gone: Other studies have shown promise in optimizing pharmacotherapy for seniors with cognitive impairments, indicating that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND, * referred to the pharmacist, for the FMGs exposed * taking prescription medications Exclusion Criteria: * Seniors in palliative care OR * unable to answer questionnaires in French AND without a caregiver.
Where it's running
-
GMF Bordeaux-Cartierville
Montreal, Quebec, Canada Recruiting -
GMF Abénakis
Saint-Georges, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Line Guénette, Ph.D
- Email: line.guenette@pha.ulaval.ca
- Phone: 418-682-7511
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validation of Italian cognitive assessment scales for elderly patients
This study is trying to see if new Italian versions of cognitive and daily living assessments can help doctors better diagnose neurodegenerative diseases in older Italian-speaking patients.
-
Exergaming for improving health in dementia patients
This study is testing if playing active dance video games three times a week can help improve movement, thinking skills, and mood in older adults with dementia living in care facilities.
-
Therapeutic patient education for adults with obesity and metabolic disorders
Aimed at adults with obesity, this study tests whether a co-developed therapeutic patient education program is acceptable and feasible to help with daily self-management.
-
Shorter Salvage Radiotherapy after Prostate Surgery for Recurrent Prostate Cancer
This study tests whether a shorter, 4-week salvage radiotherapy schedule is as safe and effective as the standard 5-week schedule for men with prostate cancer that has come back after surgery.
-
Dutasteride to prevent recurrence of low-grade non-muscle invasive bladder cancer
This will see if taking the oral medicine dutasteride can lower the chance that low-grade non-muscle invasive bladder cancer comes back in adults.
-
Four-timepoint PET scans with three tracers to map differences between prostate cancer metastases
This will test whether repeating PET scans with three different tracers can map active, treatment‑resistant versus treatment‑sensitive metastases in men with metastatic castration‑resistant prostate cancer who have at least three metastases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.